Aurobindo Pharma shares up nearly 2% on USFDA approval for nasal spray, The share touched a 52-week high of Rs 1,177 on January 30, 2024, and a 52-week low of Rs 466 on March 21, 2023.Aurobindo Pharma's share price rose nearly 2 percent in the early trade on March 20 after the company received US Food & Drug Administration (USFDA) approval for nasal spray.At 9.18 am, Aurobindo Pharma was quoting a...

Indian benchmark indices are likely to open on a negative note, hinted SGX Nifty. Ahead of the weekly F&O expiry session, Nifty futures were trading 0.5% lower at 18,123 level on the Singapore Exchange. In the previous session, the BSE Sensex rallied 390 pts to 61,046, while NSE Nifty 50 jumped 112 points to 18,165. “We expect the recovery to extend further as Nifty has surpassed the immediate h...

Indian equity markets may open in green, hinted SGX Nifty ahead of week’s last trading session. Nifty futures were trading 37 points or 0.21% up at 17,606 signalling a positive start for BSE Sensex, NSE Nifty 50. “Markets are showing tremendous resilience amid weak global cues and the recent consolidation should be seen as a breather, to digest the gains. We thus recommend continuing with the ...

Indian equity markets are likely to witness a muted start on Friday. Entering the session, Nifty futures traded 12.5 points, or 0.07% lower at 17,676 on the Singapore Exchange, signaling that Dalal Street was headed for a flat to negative open. “The technical landscape for Nifty is likely to be positive as long as the benchmark trades above its biggest support level at 17377 with targets at 1788...

Here is the list of the top 10 stocks that are likely to be in focus on Tuesday:Aurobindo Pharma: Aurobindo Pharma Ltd on Monday said it has acquired the domestic formulation business of Veritaz for a consideration of Rs171 crore on debt-free cash-free basis. This acquisition vehicle will greatly help Aurobindo as a launch pad for marketing biosimilar and other products in India, the company said ...